Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumour growth dynamics.

J V Watson1

  • 1MRC Clinical Oncology Unit, The Medical School, Cambridge, UK.

British Medical Bulletin
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Tumour growth differs significantly from cell cycle rates due to cell loss and reduced growth fraction. New techniques quantify tumor cell production for targeted cancer treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A brief history of numbers and statistics with cytometric applications.

Cytometry·2001
Same author

Proof without prejudice revisited: immunofluorescence histogram analysis using cumulative frequency subtraction plus ratio analysis of means.

Cytometry·2000
Same author

Characteristics of a novel deep red/infrared fluorescent cell-permeant DNA probe, DRAQ5, in intact human cells analyzed by flow cytometry, confocal and multiphoton microscopy.

Cytometry·2000
Same author

Mammalian S-phase checkpoint integrity is dependent on transformation status and purine deoxyribonucleosides.

Journal of cell science·2000
Same author

The early fluidic and optical physics of cytometry.

Cytometry·1999
Same author

Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

Journal of clinical pathology·1998
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
Same journal

Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

British medical bulletin·2026
Same journal

Moral injury in healthcare workers: causes & interventions.

British medical bulletin·2026
See all related articles

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Tumor growth often follows exponential patterns with doubling times of weeks to months.
  • Cell cycle completion in most cell types occurs within hours, contrasting with tumor growth rates.
  • Normal tissues maintain a steady state renewal system, unlike deregulated tumor proliferation.

Purpose of the Study:

  • To explain the discrepancy between tumor growth rates and cellular replication times.
  • To highlight the role of cell loss and growth fraction in tumor proliferation.
  • To introduce quantitative methods for assessing tumor cell production and their therapeutic implications.

Main Methods:

  • Comparison of tumor doubling times with cellular cell cycle durations.
  • Analysis of factors contributing to tumor growth, including cell loss and growth fraction.

Related Experiment Videos

  • Application of newly available techniques to quantify the rate constant for cell production in human tumors.

    • Main Results:

    • Identified cell loss and a growth fraction less than unity as key reasons for slower tumor growth compared to cell cycle speed.
    • Established that tumor growth signifies a breakdown in normal regulatory feedback mechanisms.
    • Demonstrated the availability of techniques to quantify tumor cell production rates.

    Conclusions:

    • Tumor growth dynamics are distinct from normal tissue renewal due to regulatory failures.
    • Quantitative assessment of tumor cell production is now feasible.
    • These quantitative measurements can inform the design of specific treatments for individual tumors.